Shares in Natco Pharma and Cipla gain after the Supreme Court on Monday dismissed Swiss drugmaker Novartis AG's petition seeking patent for its cancer drug Glivec.In a landmark judgment that has......
The US Food and Drug Administration warned Novartis AG last week after the Swiss firm was found in violation of manufacturing practices last year at two of its India drug-making plants, Novartis......
The Delhi High Court has barred generic drugmaker Cipla Ltd from making or selling a cheaper copy of Novartis AG's respiratory drug Onbrez domestically, citing infringement of patents......
Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering......
Tearing into the allegations made by Novartis on India's 'discriminatory' patent practices, the government has said global firms, including the Swiss drug major, have benefited more from the......